- Home
- MTRX vs LAB Comparison
MTRX vs LAB Comparison
Compare MTRX & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTRX
- LAB
- Stock Information
- Founded
- MTRX 1984
- LAB 1999
- Country
- MTRX United States
- LAB United States
- Employees
- MTRX N/A
- LAB N/A
- Industry
- MTRX Engineering & Construction
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- MTRX Consumer Discretionary
- LAB Industrials
- Exchange
- MTRX Nasdaq
- LAB Nasdaq
- Market Cap
- MTRX 327.8M
- LAB 372.1M
- IPO Year
- MTRX 1990
- LAB 2011
- Fundamental
- Price
- MTRX $14.00
- LAB $1.35
- Analyst Decision
- MTRX Strong Buy
- LAB Buy
- Analyst Count
- MTRX 1
- LAB 2
- Target Price
- MTRX $20.00
- LAB $2.50
- AVG Volume (30 Days)
- MTRX 194.3K
- LAB 2.6M
- Earning Date
- MTRX 05-07-2025
- LAB 07-30-2025
- Dividend Yield
- MTRX N/A
- LAB N/A
- EPS Growth
- MTRX N/A
- LAB N/A
- EPS
- MTRX N/A
- LAB N/A
- Revenue
- MTRX $742,408,000.00
- LAB $169,687,000.00
- Revenue This Year
- MTRX $9.98
- LAB N/A
- Revenue Next Year
- MTRX $20.42
- LAB $12.18
- P/E Ratio
- MTRX N/A
- LAB N/A
- Revenue Growth
- MTRX N/A
- LAB 33.86
- 52 Week Low
- MTRX $8.61
- LAB $0.92
- 52 Week High
- MTRX $15.75
- LAB $2.41
- Technical
- Relative Strength Index (RSI)
- MTRX 66.73
- LAB 64.54
- Support Level
- MTRX $13.31
- LAB $1.15
- Resistance Level
- MTRX $14.07
- LAB $1.31
- Average True Range (ATR)
- MTRX 0.41
- LAB 0.11
- MACD
- MTRX 0.10
- LAB 0.03
- Stochastic Oscillator
- MTRX 89.40
- LAB 57.89
About MTRX Matrix Service Company
Matrix Service Co is an engineering and construction provider for large industrial projects, primarily in the oil and gas, power, petrochemical, industrial, mining, and minerals markets. It offers engineering, fabrication, construction, and maintenance services, operating across three segments namely Utility and Power Infrastructure; Process and Industrial Facilities; and Storage and Terminal Solutions.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.